- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07355673
The Influence of Isolation Techniques in Gingival Irritation During an In-office Bleaching
A Double Blind Randomized Clinical Trial Comparing the Risk of Gingival Irritation of Two Different Isolation Techniques Performed During In-Office Bleaching
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
- Visit 1: Study information and delivery of informed consent. Recording of patient's medical history, general examination, and prophylaxis. Alginate impressions will be taken of the upper and lower arches for all the patients who meet the inclusion criteria. The impressions will be poured into plaster, and a positioning guide-finder tray will be fabricated for each patient for color measurement.
- Visit 2: Initial color measurement with a spectrophotometer and the positioning guide. Two clinicians performed the assigned isolation technique (relative or absolute). Then after a correct isolation the clinicians apply over the buccal surface from premolar to premolar of both arches the bleaching agent (Opalescence Boost 40%, Ultradent Products, South Jordan, USA).Two application of 20 minutes each. Objective examination of gingival tissues was performed visually, documented with photographs, and verified using a periodontal probe. The sensitivity was recorded and patient were given a sensitivity test to record at home. c) Visit 3: One week after the first bleaching session. Color measurement with a spectrophotometer and the positioning guide. In this visit the second bleaching session was done with the same steps as visit 2. d) Visit 4: 15 days after the second bleaching session. Final data collection (color + patients sensitivity test)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
A Coruña
-
Santiago de Compostela, A Coruña, Spain, 15705
- School of Medicine and Dentistry
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- No oral os systemic pathology
- Periodontally Healthy
- No cavities
- Tooth shade of the canines A2 or darker
Exclusion Criteria:
- Adhesive restorations or protheses in the anterior region
- Enamel or dentin alterations
- Smoking habits
- Pregnant women
- Undergone prior bleaching treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Relative Isolation
The relative isolation technique consists in inserting a lip retractor (OptraGate, Ivoclar Vivadent) and applying a gingival barrier resin (OpalDam, Ultradent Products) along the gingival margin, extending approximately 2-3 mm onto the enamel.
|
General Examination with bite-wings, dental prophylaxis, alginate impressions of both arches, creation of individualized bleaching trays and position finder trays. .
Relative isolation of the gingival tissues.
Two applications of the bleaching agent of 20 minutes
|
|
Experimental: Absolute isolation
The total rubber dam isolation was carried out placing the dam (Flexidam non latex; Roeko) from premolar to premolar in both arches and stabilizing it with clamps (B4; Hygenic).
Dental silk ligatures were used to achieve proper cervical retraction.
|
General Examination with bite-wings, dental prophylaxis, alginate impressions of both arches, creation of individualized bleaching trays and position finder trays. .
Absolute isolation of the gingival tissues.
Two applications of the bleaching agent of 20 minutes
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gingival Evaluation Recording
Time Frame: -15 minutes after the first bleaching session - 15 minutes after the second bleaching session
|
Objective examination of gingival tissues was performed visually, documented with photographs, and verified using a periodontal probe.
Patients were classified according to the Löe and Silness' gingival index as follows: G0 =normal gingiva; G1=mild inflammation (slight color change, slight edema, no bleeding on probing); G2=moderate inflammation (redness, edema, glazing, bleeding on probing); and G3=severe inflammation (marked redness and edema, ulceration, spontaneous bleeding).
|
-15 minutes after the first bleaching session - 15 minutes after the second bleaching session
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionary of dental sensitivity
Time Frame: Perioperative , 1 hour postoperative, 24 hours postoperative, 48 hours postoperative.
|
General tooth sensitivity was assessed using a 5-point Numeric Rating Scale (NRS), where 0 = no sensitivity; 1 = mild discomfort; 2 = moderate discomfort that does not interfere with daily activities; 3 = considerable discomfort leading to avoidance of certain foods and beverages; and 4 = severe sensitivity requiring interruption of the bleaching treatment. Participants selected the numeric value that best represented their perceived level of tooth sensitivity. Pain intensity was recorded at the following time points:
|
Perioperative , 1 hour postoperative, 24 hours postoperative, 48 hours postoperative.
|
|
Shade evaluation of each patient
Time Frame: Baseline, Before the first bleaching session, Revision (1 week after the 2 bleaching session)
|
Tooth color will be measured using a dental spectrophotometer, recording the following parameters: L (lightness, representing the shade from black to white on a scale of 0 to 100), a (color variation along the red-green axis, with positive values toward red/purple and negative values toward green/blue), b (color variation along the yellow-blue axis, with positive values toward yellow and negative values toward blue/purple), C (chroma, describing the intensity or saturation of a color, expressed on a scale from 0 to 40, where 0 indicates no saturation and 40 the maximum saturation), and hº (hue, representing the dominant wavelength of a color on a continuous circular scale from 0° to 360°). Color changes between visits will be calculated using the CIELab, CIEDE2000, and White Index for Dentistry (WID) formulas. Color measurements will be recorded at the following time points: Baseline (Bleaching Day 1) One week after baseline (Before Bleaching Day 2) Follow-up (One week after) |
Baseline, Before the first bleaching session, Revision (1 week after the 2 bleaching session)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2025/02
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gingival Irritation
-
Universidad Rey Juan CarlosCompletedPatient Satisfaction | Tooth Sensitivity | Bleaching Efficacy | Gingival IrritationSpain
-
Galderma R&DCompleted
-
University Hospitals Cleveland Medical CenterNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompleted
-
Ventrus Biosciences, IncUnknownSkin IrritationUnited States
-
Galderma R&DCompletedSkin IrritationUnited States
-
Pulmatrix Inc.Completed
-
Amazentis SAPrinceton Consumer ResearchRecruitingIrritation/Irritant | SensitisationUnited Kingdom
-
Amazentis SAPrinceton Research CorporationCompletedIrritation/Irritant | SensitisationUnited Kingdom
-
LEO PharmaCompleted
-
Amazentis SAPrinceton Research CorporationCompletedIrritation/Irritant | SensitisationUnited Kingdom
Clinical Trials on Relative Isolation
-
Federal University of PelotasCompleted
-
University of Sao PauloCompletedDental Caries in ChildrenBrazil
-
Air Force Military Medical University, ChinaCompletedAcute Leukemia | Childhood Cancer | Cardiac ToxicityChina
-
The University of Texas Health Science Center,...Recruiting
-
Asociación Científica Latina A.C.Universidad Autonoma del Estado de MexicoCompletedRheumatoid Arthritis
-
PfizerCompletedHealthy ParticipantsUnited States
-
University Hospital Inselspital, BerneRecruiting
-
Nazarbayev UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisAgence de La Biomédecine; Fondation de FranceCompletedTissue and Organ Procurement | Death, Assisted | Life Support CareFrance
-
Ante KresoUniversity Hospital of Split; University of Split, School of MedicineNot yet recruitingOcular Biometry | Hydration Status | Macular Thickness